
Idexx Laboratories (IDXX) is a health care equipment company in the Health Care sector. Listed on the NASDAQ, Idexx Laboratories is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $556.94.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $556.94 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 5.12% |
| Risk / Std Dev (Annualized) | 35.34% |
| Sharpe Ratio (rf=4.5%) | 0.02 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Health Care Equipment
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 5.12% with an annualized volatility of 35.34%. The Sharpe ratio of 0.02 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 43.93B |
| Enterprise Value | 44.84B |
| Trailing P/E | 40.98 |
| Forward P/E | 33.72 |
| Price to Book | 28.36 |
| Price to Sales | 9.88 |
| EV/Revenue | 10.09 |
| EV/EBITDA | 29.0 |
| Profitability | | | Profit Margin | 24.63% | | Operating Margin | 31.78% | | ROE | 72.91% | | ROA | 26.46% |
| Growth | | | Revenue Growth | 14.3% | | Earnings Growth | 17.2% |
| Financial Health | | | Total Revenue | 4.45B | | Total Debt | 1.11B | | Total Cash | 0.2B | | Free Cash Flow | 0.79B | | Operating Cash Flow | 1.21B |
| Price & Technical | | | 52W High | $769.98$ | | 52W Low | $506.91$ | | 50-Day Avg | $563.25$ | | 200-Day Avg | $635.4$ | | Beta | 1.54 | | Shares Outstanding | 0.08B | | Float Shares | 0.08B | | Insider Holdings | 0.22% | | Institutional Holdings | 96.15% | | Short Ratio | 3.26 | | Short % of Float | 3.16% |
| Analyst Targets | | | Target High | $805.0$ | | Target Low | $470.0$ | | Target Mean | $709.14$ | | Target Median | $712.5$ | | # of Analysts | 14 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.